Key facts
- It has raised $62.2M; the latest was Later Stage VC ($18.2M) in May 2024.
- Notable investors include Georg Von Werz, Horizon 2020, Jens Ulrik Holst, Juergen Hambrecht, Jürgen Hambrecht — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for RSP Systems
- ·The full record, as it builds
Funding rounds
No funding rounds for RSP Systems are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RSP Systems
Developer of a non-invasive glucose monitoring device intended to improve the health and quality of life of people with diabetes worldwide. The company's device measures blood glucose by shining a laser at the molecules and measuring the frequency change of the returning light in the interstitial fluid without a blood sample, enabling users to get a convenient and pain-free alternative to the current invasive systems.
- Sector
- Healthcare
- HQ
- Odense S, Denmark
- Founded
- 2006
- Employees
- 24
- Website
- rspsystems.com/
- Ownership
- Privately Held (backing)
RSP Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RSP Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RSP Systems in its N-PORT filings yet. We sweep new filings monthly.